Application of DLPTP to 2D-TPP datasets profiling the HDAC8 inhibitor PCI-34051 and its analog BRD-3811 let us discover that both compounds inhibit LAP3, an interesting ovarian and liver cancer target. Here, HDAC8 is linked to liver cancer.